Orphagen Pharmaceuticals Receives Rare Pediatric Disease Designation from FDA for OR-449 for the Treatment of Pediatric Adrenocortical Carcinoma Read more
CARsgen Therapeutics and Huadong Medicine Announce Collaboration Agreement For Zevorcabtagene Autoleucel In Mainland China Read more
Roche announces the European Commission approval of Xofluza for the treatment and prevention of influenza in children aged one year and above Read more
Sabin Vaccine Institute Receives $35 Million from BARDA with Potential of up to $214 Million for Ebola Sudan and Marburg Vaccines Read more
Ono Enters an Option and Research Collaboration Agreement with Monash University to Discover Anti-GPCR Antibodies in the Autoimmune and Inflammatory Diseases Read more
FDA Approves Luye Pharma’s Rykindo for the Treatment of Schizophrenia and Bipolar 1 Disorder Read more